Galectins and cancer

Biochimica et Biophysica Acta - General Subjects

Volumn 1572, Issue 2-3, 2002, Pages 285-293

  Danguy, André ^a   Camby, Isabelle ^a   Kiss, Robert ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Cancer; Galectin; Metastasis

Indexed keywords

GALECTIN;

ADIPOSE TISSUE; BINDING SITE; BLADDER CARCINOMA; BREAST CARCINOMA; CELL LINE; CENTRAL NERVOUS SYSTEM; COLON CARCINOMA; ENDOMETRIUM CARCINOMA; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; LYMPHOID TISSUE; MOLECULAR BIOLOGY; MUSCLE TISSUE; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; STOMACH CARCINOMA; THYROID CARCINOMA;

ADIPOSE TISSUE; ANIMALS; CARCINOMA; GALECTINS; HEMAGGLUTININS; HUMANS; LECTINS; LYMPHOID TISSUE; MUSCLES; NEOPLASMS; PROGNOSIS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

MAMMALIA;

EID: 0037136411     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(02)00315-X     Document Type: Review

References (63)

1. Barondes S.H., Castronovo V., Cooper D.N.W., Cummings R.D., Drickamer K., Freizi T., Gitt M.A., Hirabayashi J., Hughes R.C., Kasai K., Leffler H., Liu F.T., Lotan R., Mercurio A.M., Monsigny M., Pillai S., Poirier F., Raz A., Rigby P.W., Rini J.M., Wang J.L. Galectins: a family of animal β-galactoside-binding lectins. Cell. 76:1994;597-598.
2. Barondes S.H., Cooper D.N.W., Gitt M.A., Leffler H. Galectins. Structure and function of a large family of animal lectins. J. Biol. Chem. 269:1994;20807-20810.
3. Kasai K.I., Hirabayashi J. Galectins: a family of animal lectins that decipher glycocodes. J. Biochem. 119:1996;1-8.
4. Hughes R.C. Galectins as modulators of cell adhesion. Biochimie. 83:2001;667-676.
5. Hirabayashi J. Recent topics on galectins. Trends Glycosci. Glycotechnol. 9:1997;1-180.
6. Loris R. Principles of structures of animal and plant lectins. Biochim. Biophys. Acta. 1572:2002;198-208.
7. Gabius H.-J., Andre S., Kaltner H., Siebert H.-C. The sugar code: functional lectinomics. Biochim. Biophys. Acta. 1572:2002;165-177.
8. Perillo N.L., Marcus M.E., Baum L.G. Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death. J. Mol. Med. 76:1998;402-412.
9. Lotan R., Ito H., Yasui W., Yokosaki H., Lotan D., Tahara E. Expression of a 31 kDa lactose binding lectin in normal human gastric mucosa and in primary and metastatic gastric carcinoma. Int. J. Cancer. 56:1994;474-480.
10. Hsu D.K., Dowling G.A., Jeng K.C., Chen J.T., Yang R.Y., Liu F.T. Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma. Int. J. Cancer. 81:1999;519-526.
11. Irimura T., Matsushita Y., Sutton R.C., Carritero D., Ohannesian D.W., Cleary K.R., Ota D.M., Nicolson G.L., Lotan R. Increased content of an endogenous lactose-binding lectin in human colorectal carcinoma progressed to metastasis stages. Cancer. 51:1991;387-393.
12. Lee E.C., Woo H.J., Korzelius C.A., Steele G.E., Mercurio A.M. Carbohydrate-binding protein 35 is the major cell-surface laminin-binding protein in colon carcinoma. Arch. Surg. 126:1991;1496-1502.
13. Lotz M.M., Andrews C.W. Jr., Korzelius C.A., Lee E.C., Steele G.D. Jr., Clarke A., Mercurio A.M. Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. Proc. Natl. Acad. Sci. U.S.A. 90:1993;3466-3470.
14. Schoeppner H.L., Raz A., Ho S.B., Bresalier R.S. Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon. Cancer. 75:1995;2818-2826.
15. San Juan X., Fernandez P.L., Castells A., Castronovo V., Van den Brule F., Liu F.T., Cardesa A., Campo E. Differential expression of galectin 3 and galectin 1 in colorectal cancer progression. Gastroenterology. 113:1997;1906-1915.
16. Bresalier R.S., Mazurek N., Sternberg L.R., Byrd J.C., Yunker C.K., Nangia-Makker P., Raz A. Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding protein galectin 3. Gastroenterology. 115:1998;287-296.
17. Berberat O.P., Friess H., Wang L., Zhu Z., Bley T., Frigeri L., Zimmermann A., Büchler M.W. Comparative analysis of galectins in primary tumors and tumor metastasis in human pancreatic cancer. J. Histochem. Cytochem. 49:2001;539-549.
18. Danguy A., Rorive S., Decaestecker C., Bronckart Y., Kaltner H., Hadari Y.R., Goren R., Zich Y., Petein M., Salmon I., Gabius H.J., Kiss R. Immunohistochemical profile of galectin-8 expression in benign and malignant tumors of epithelial, mesenchymatous and adipous origins, and the nervous system. Histol. Histopathol. 16:2001;861-868.
19. Nagy N., Bronckart Y., Camby I., Legendre H., Lahm H., Kaltner H., Hadari Y., Van Ham P., Yeaton P., Pector J.-C., Zick Y., Salmon I., Danguy A., Kiss R., Gabius H.-J. Galectin-8 expression decreases in cancer compared with normal and dysplasic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor. Gut. 50:2002;392-401.
20. Chiariotti L., Berlingieri M.T., De Rosa P. Increased expression of the negative growth factor, galactoside-binding protein, gene in transformed thyroid cells and in human thyroid carcinomas. Oncogene. 7:1992;2507-2511.
21. Chiariotti L., Berlingieri M.T., Battaglia C., Benvenuto G., Martelli M.L., Salvatore P., Chiappetta G., Bruni C.B., Fusco A. Expression of galectin-1 in normal human thyroid gland and in differentiated and poorly differentiated thyroid tumors. Int. J. Cancer. 64:1995;171-175.
22. Xu X.C., El-Naggar A.K., Lotan R. Differential expression of galectin-1 and galectin-3 in thyroid tumors: potential diagnostic implications. Am. J. Pathol. 147:1995;815-822.
23. Fernandez P.L., Merino M.J., Gomez M., Campo E., Medina T., Castronovo V., San Juan X., Cardesa A., Liu F.T., Sobel M.E. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue. J. Pathol. 181:1997;80-86.
24. Cvejic D., Savin S., Paunovic I., Tatic S., Havelka M., Sinadinovic J. Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue. Anticancer Res. 18:1998;2637-2641.
25. Orlandi F., Saggiorato E., Pivano G., Puligheddu B., Termine A., Cappia S., De Giuli P., Angeli A. Galectin-3 is a presurgical marker of human thyroid carcinoma. Cancer Res. 58:1998;3015-3020.
26. Kawachi K., Matsuchita Y., Yonezawa S., Nakano S., Shirao K., Natsugoe S., Sueyoshi K., Aikou T., Sato E. Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation. Hum. Pathol. 31:2000;428-433.
27. Van den Brûle F.A., Buicu C., Berchuck A., Bast R.C., Deprez M., Liu F.T., Cooper D.N.W., Pieters C., Sobel M.E., Castronovo V. Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinoma. Hum. Pathol. 27:1996;1185-1191.
28. Van den Brûle F.A., Berchuck A., Bast R.C., Liu F.T., Gillet C., Sobel M.E., Castronovo V. Differential expression of the 67-kD laminin receptor and 31-kD human laminin binding protein in human ovarian cancer. Eur. J. Cancer. 30A:1994;1096-1099.
29. Gabius H.-J., Brehler R., Schauer A., Cramer F. Localization of endogenous lectins in normal human breast, benign breast lesions and mammary carcinomas. Virchows Arch., B Pathol. 52:1986;107-115.
30. Castronovo V., Van den Brûle F.A., Jackers P., Clausse N., Liu F.T., Gillet C., Sobel M.E. Decreased expression of galectin-3 is associated with progression of human breast cancer. J. Pathol. 179:1996;43-48.
31. Idikio H. Galectin-3 expression in human breast carcinoma: correlation with cancer histologic grade. Int. J. Oncol. 12:1998;1287-1290.
32. Kim H.R.C., Liu H.M., Biliran H., Raz A. Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells. Cancer Res. 59:1999;4148-4154.
33. Van den Brûle F.A., Waltregny D., Castronovo V. Increased expression of galectin-1 in carcinoma-associated stroma predicts poor outcome in prostate carcinoma patients. J. Pathol. 193:2001;80-87.
34. Su Z.Z., Lin J., Shen R., Fisher P.E., Goldstein N.I., Fisher P.B. Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family. Proc. Natl. Acad. Sci. U.S.A. 93:1996;7252-7257.
35. Sheikholeslam-Zadeh R., Decaestecker C., Delbrouck C., Danguy A., Salmon I., Zich Y., Kaltner H., Hassid S., Gabius H.J., Kiss R., Choufani G. The levels of expression of galectin-3, but not of galectin-1 and galectin-8, correlate with apoptosis in human cholesteatomas. Laryngoscope. 111:2001;1042-1047.
36. Choufani G., Nagy N., Saussez S., Marchant H., Bisschop P., Burchert M., Danguy A., Louryan S., Salmon I., Gabius H.J., Kiss R., Hassid S. The levels of expression of galectin-1, galectin-3, and the Thomsen-Friedenreich antigen and their binding sites decrease as clinical aggressiveness increases in head and neck cancers. Cancer. 86:1999;2353-2363.
37. Delorge S., Saussez S., Pelc P., Devroede B., Marchant H., Burchert M., Zeng F.Y., Danguy A., Salmon I., Gabius H.J., Kiss R., Hassid S. Correlation of galectin-3/galectin-3 binding sites with low differentiation status in head and neck squamous cell carcinomas. Otolaryngol. Head Neck Surg. 122:2000;834-841.
38. François C., Van Velthoven R., De Lathouwer O., Moreno C., Peltier A., Kaltner H., Salmon I., Gabius H.J., Danguy A., Decaestecker C., Kiss R. Galectin-1 and galectin-3 binding pattern expression in renal cell carcinomas. Am. J. Clin. Pathol. 112:1999;194-203.
39. Konstantinov K., Robbins B.C., Liu F.T. Galectin-3, a β-galactoside-binding animal lectin, is a marker of anaplastic large-cell lymphoma. Am. J. Pathol. 148:1996;25-30.
40. Hsu D.K., Hammes S.R., Kuwabara I., Greene W.C., Liu F.T. Human T lymphotropic virus-I infection of human T lymphocytes induces expression of the beta-galactoside-binding lectin galectin-3. Am. J. Pathol. 148:1996;1661-1670.
41. Schwarz G., Remmelink M., Decaestecker C., Gielen I., Budel V., Burchert M., Darro F., Danguy A., Gabius H.J., Salmon I., Kiss R. Galectin fingerprinting in tumor diagnosis. Differential expression of galectin-3 binding sites, but not galectin-1, in benign vs malignant uterine smooth muscle tumors. Am. J. Clin. Pathol. 111:1999;623-631.
42. Caron M., Chadli A., Botti J., Joubert-Caron R. Lectins in human brain: some characteristics of the 14 KDA β-galactoside-binding lectin. Van Driessche E., Fischer J., Beckmans S., Bog-Hansen T.C. Lectins: Biology, Biochemistry, Clinical Biochemistry. 1994;227-233 Textop, Hellerup, Denmark.
43. Regan L.J., Dodd J., Barondes S.H., Jessel J.M. Selective expression of endogenous lactose-binding lectins and lactoseries glycoconjugates in subsets of rat sensory neurons. Proc. Natl. Acad. Sci., USA. 83:1986;2248-2252.
44. Saada A., Reichert F., Rotshenker S. Granulocyte macrophage colony stimulating factor produced in lesioned peripheral nerves induces the up-regulation of cell surface expression of MAC-2 by macrophages and Schwann cells. J. Cell Biol. 133:1996;159-167.
45. Probstmeier R., Montag D., Schachner M. Galectin-3, a β-galactoside-binding animal lectin, binds to neural recognition molecules. J. Neurochem. 64:1995;2465-2472.
46. Bresalier R.S., Yan P.S., Byrd J.C., Lotan R., Raz A. Expression of the endogenous galectose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system. Cancer. 80:1997;776-787.
47. Gordower L., Decaestecker C., Kacem Y., Lemmers A., Gusman J., Burchert M., Danguy A., Gabius H.J., Salmon I., Kiss R., Camby I. Galectin-3 and galectin-3 binding site expression in human adult astrocytic tumours and related angiogenesis. Neuropathol. Appl. Neurobiol. 25:1999;319-330.
48. Ochieng J., Green B., Evans S., James O., Warfield P. Modulation of the biological functions of galectin-3 by matrix metalloproteinases. Biochem. Biophys. Acta. 1379:1998;97-106.
49. Romanic A.M., Madri J.A. Extracellular matrix-degrading proteinases in the nervous system. Brain Pathol. 4:1994;145-156.
50. Camby I., Belot N., Rorive S., Lefranc F., Maurage C.A., Lahm H., Kaltner H., Hadari Y., Ruchoux M.M., Brotchi J., Zick Y., Salmon I., Gabius H.J., Kiss R. Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration. Brain Pathol. 11:2001;12-26.
51. Yamaoka K., Mishima K., Nagashima Y., Asai A., Sanai Y., Kirino T. Expression of galectin-1 mRNA correlates with the malignant potential of human gliomas and expression of antisense galectin-1 inhibits the growth of 9 glioma cells. J. Neurosci. Res. 59:2000;722-730.
52. Rorive S., Belot N., Decaestecker C., Lefranc F., Gordower L., Micik S., Maurage C.A., Kaltner H., Ruchoux M.M., Danguy A., Gabius H.J., Salmon I., Kiss R., Camby I. Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyme. Glia. 33:2001;241-255.
53. Van den Brûle F.A., Buicu C., Baldet M., Sobel M.E., Cooper D.N.W., Marschal P., Castronovo V. Galectin-1 modulates human melanoma cell adhesion to laminin. Biochem. Biophys. Res. Commun. 209:1995;760-767.
54. Inohara H., Raz A. Identification of human melanoma cellular and secreted ligands for galectin-3. Biochem. Biophys. Res. Commun. 201:1994;1366-1375.
55. Mey A., Berthier-Vergnes O., Apoil P.A., Doré J.F., Revillard J.P. Expression of the galactose binding protein Mac-2 by human melanoma cell lines. Cancer Lett. 81:1994;155-163.
56. Lahm H., André S., Hoeflich A., Fischer J.R., Sordat B., Kaltner H., Wolf E., Gabius H.J. Comprehensive galectin fingerprinting in a panel of 61 human cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures. J. Cancer Res. Clin. Oncol. 127:2001;375-386.
57. André S., Kojima S., Yamazaki N., Fink C., Kaltner H., Kayser K., Gabius H.J. Galectins-1 and -3 and their ligands in tumor biology. J. Cancer Res. Clin. Oncol. 125:1999;461-474.
58. Makker P.N., Thompson E.W., Hogan C., Ochieng J., Raz A. Induction of tumorigenicity by galectin-3 in a non-tumorigenic human breast carcinoma cell line. Int. J. Oncol. 7:1995;1079-1087.
59. Warfield P.R., Makker P.N., Raz A., Ochieng J. Adhesion of human breast carcinoma to extracellular matrix proteins is modulated by galectin-3. Invasion Metastasis. 17:1997;101-112.
60. Ochieng J., Warfield P., Green-Jarvis B., Fentie I. Galectin-3 regulates the adhesive interaction between breast carcinoma cells and elastin. J. Cell. Biochem. 75:1999;505-514.
61. Willett W.C., Colditz G.A., Mueller N.E. Strategies for minimizing cancer risk. Sci. Am. 275:1996;58-63.
62. Laine R.A. The information-storing potential of the sugar code. Gabius H.J., Gabius S. Glycoscience. Status and Perspectives. 1997;1-14 Chapman & Hall, London.
63. Liu F.-T., Patterson R.J., Wang J.L. Intracellular functions of galectins. Biochim. Biophys. Acta. 1572:2002;263-273.